Uso del Heberprot-P® en paciente con Pie Diabético
Medimay, 2019 El pie diabético es una alteración clínica de base etiopatogénica neuropática e inducida por la hiperglucemia mantenida. Se presenta este caso clínico con el objetivo de mostrar la efectividad del uso del Heberprot-p® en el tratamiento del pie diabético.
Rafael Miranda Pedroso
doaj
Cross-cultural adaptation and validation of the Diabetic Foot Questionnaire (DiaFootQ) into Spanish Language. [PDF]
Aten PrimariaRuiz-Muñoz M +5 more
europepmc +1 more source
[The impact of the COVID-19 pandemic on the control of chronic diseases in primary care]. [PDF]
Aten Primaria, 2022 Caparrós Boixés G +3 more
europepmc +1 more source
Surgical treatment of diabetic foot: a spatial analysis, Ceará, Brazil, 2016-2021. [PDF]
Epidemiol Serv SaudeFeitosa YS +6 more
europepmc +1 more source
[Effectiveness of a home kinesiology exercise plan on activity limitation in subjects with diabetic foot] [PDF]
Rev Fac Cien Med Univ Nac CordobaGiménez V, Olsen MA.
europepmc +1 more source
Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population. [PDF]
Int J Cardiol Cardiovasc Risk Prev, 2023 Rizo Rivera GO +6 more
europepmc +1 more source
Diabetic foot care and cardiovascular surgery in Peru: a looming crisis of centralism and unequal resource allocation. [PDF]
Arch Peru Cardiol Cir CardiovascCubas WS.
europepmc +1 more source
[Design and validation of a visual didactic tool for diabetic foot prevention]. [PDF]
Aten PrimariaHernández Lucero NL +4 more
europepmc +1 more source
Clinical decision support systems for diabetic foot ulcers: a scoping review. [PDF]
Rev Esc Enferm USPGarces TS +10 more
europepmc +1 more source
[Resources and models for diabetic foot care in Catalonia (Spain): a descriptive study on areas of improvement]. [PDF]
Aten Primaria, 2012 Jurado-Campos J +5 more
europepmc +1 more source